Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $1.53 by 3.27 percent. This is a 15.51 percent decrease over earnings of $1.87 per share from the same period last year.
Wells Fargo Maintains Equal-Weight on PVH, Lowers Price Target to $70
Wells Fargo analyst Ike Boruchow maintains PVH (NYSE:PVH) with a Equal-Weight and lowers the price target from $80 to $70.
